FDA Aims To 'Pierce The Rhetoric' On Generic Application Backlog

ANDA backlog is now largely cleared, FDA's Uhl notes, 'and in many cases we've actually gone above and beyond our negotiated commitments in order to really meet the stakeholder expectations.'